Bridgeway Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.8K | Buy |
25,000
+12,516
| +100% | +$46.4K | ﹤0.01% | 1082 |
|
|
2025
Q1 | $40.3K | Buy |
+12,484
| New | +$40.3K | ﹤0.01% | 1132 |
|
|
2024
Q1 | – | Sell |
-17,400
| Closed | -$353K | – | 1332 |
|
|
2023
Q4 | $353K | Sell |
17,400
-10,000
| -36% | -$203K | 0.01% | 1030 |
|
|
2023
Q3 | $349K | Hold |
27,400
| – | – | 0.01% | 977 |
|
|
2023
Q2 | $495K | Hold |
27,400
| – | – | 0.01% | 903 |
|
|
2023
Q1 | $471K | Sell |
27,400
-15,000
| -35% | -$258K | 0.01% | 906 |
|
|
2022
Q4 | $942K | Sell |
42,400
-15,000
| -26% | -$333K | 0.02% | 744 |
|
|
2022
Q3 | $461K | Buy |
+57,400
| New | +$461K | 0.01% | 912 |
|